| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 40.64B | 52.11B | 45.48B | 47.07B | 41.63B | 67.13B |
| Gross Profit | 11.28B | 14.61B | 12.81B | 12.92B | 9.09B | 15.85B |
| EBITDA | 4.14B | 8.00B | 6.30B | 6.31B | 4.16B | 8.46B |
| Net Income | 3.18B | 4.86B | 3.52B | 3.51B | 2.31B | 6.27B |
Balance Sheet | ||||||
| Total Assets | 143.54B | 133.14B | 123.75B | 130.86B | 123.55B | 122.02B |
| Cash, Cash Equivalents and Short-Term Investments | 21.17B | 15.85B | 15.34B | 17.64B | 19.51B | 21.57B |
| Total Debt | 31.50B | 25.68B | 17.20B | 20.91B | 22.51B | 19.42B |
| Total Liabilities | 82.77B | 73.27B | 63.91B | 71.70B | 66.58B | 63.72B |
| Stockholders Equity | 58.43B | 57.57B | 57.14B | 56.41B | 54.74B | 56.87B |
Cash Flow | ||||||
| Free Cash Flow | 275.49M | 219.01M | -1.89B | 812.52M | 894.84M | -288.88M |
| Operating Cash Flow | 3.95B | 4.87B | 2.14B | 2.71B | 2.42B | 2.62B |
| Investing Cash Flow | -3.14B | -5.64B | -2.92B | -278.40M | 567.37M | -1.83B |
| Financing Cash Flow | 2.79B | 465.41M | -679.32M | -2.64B | -2.49B | 2.42B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | HK$13.27B | 4.32 | 11.57% | 4.26% | 9.84% | 27.75% | |
66 Neutral | HK$100.50B | 4.80 | 14.20% | 4.77% | 15.34% | 20.27% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
58 Neutral | HK$34.21B | 13.19 | 13.75% | 3.41% | 11.08% | 59.37% | |
57 Neutral | HK$71.43B | 19.02 | 7.49% | 7.28% | 14.66% | 30.39% | |
51 Neutral | HK$2.31B | 51.36 | -1.07% | ― | 5.97% | 53.11% | |
39 Underperform | HK$1.06B | -5.14 | -10.95% | ― | -10.77% | -25.12% |